Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis.

Savanna San FilippoBrynna CrovettoJohn BucekRonald G NahassMarc MilanoLuigi Brunetti

Published in: Open forum infectious diseases (2022)

There was a higher failure rate with bamlanivimab vs casirivimab/imdevimab. No difference in efficacy was found between early vs late administration of either mAb.

Keyphrases

monoclonal antibody
coronavirus disease
sars cov